ID24374A - Komposisi-komposisi parenteral alatrofloksasin - Google Patents

Komposisi-komposisi parenteral alatrofloksasin

Info

Publication number
ID24374A
ID24374A IDW20000200A ID20000200A ID24374A ID 24374 A ID24374 A ID 24374A ID W20000200 A IDW20000200 A ID W20000200A ID 20000200 A ID20000200 A ID 20000200A ID 24374 A ID24374 A ID 24374A
Authority
ID
Indonesia
Prior art keywords
alatrofloxasin
parenteral compositions
parenteral
compositions
Prior art date
Application number
IDW20000200A
Other languages
English (en)
Inventor
Robert Mark Guinn
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID24374A publication Critical patent/ID24374A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IDW20000200A 1997-08-01 1998-07-23 Komposisi-komposisi parenteral alatrofloksasin ID24374A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
ID24374A true ID24374A (id) 2000-07-13

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000200A ID24374A (id) 1997-08-01 1998-07-23 Komposisi-komposisi parenteral alatrofloksasin

Country Status (40)

Country Link
US (1) US6194429B1 (id)
EP (1) EP1000086B1 (id)
JP (1) JP3463928B2 (id)
KR (1) KR20010022495A (id)
CN (1) CN1265671A (id)
AP (1) AP1031A (id)
AR (1) AR015417A1 (id)
AT (1) ATE259827T1 (id)
AU (1) AU734863B2 (id)
BG (1) BG104105A (id)
BR (1) BR9811580A (id)
CA (1) CA2296466C (id)
CO (1) CO4970688A1 (id)
DE (1) DE69821767T2 (id)
DK (1) DK1000086T3 (id)
DZ (1) DZ2576A1 (id)
EA (1) EA002120B1 (id)
ES (1) ES2214716T3 (id)
GT (1) GT199800112A (id)
HN (1) HN1998000106A (id)
HR (1) HRP980417B1 (id)
HU (1) HUP0004793A3 (id)
ID (1) ID24374A (id)
IL (1) IL134156A0 (id)
IS (1) IS5339A (id)
MA (1) MA24626A1 (id)
NO (1) NO20000485L (id)
NZ (1) NZ502249A (id)
OA (1) OA11281A (id)
PA (1) PA8456701A1 (id)
PE (1) PE103799A1 (id)
PL (1) PL338477A1 (id)
PT (1) PT1000086E (id)
SK (1) SK1012000A3 (id)
TN (1) TNSN98146A1 (id)
TW (1) TW538043B (id)
UY (1) UY25113A1 (id)
WO (1) WO1999006430A1 (id)
YU (1) YU2500A (id)
ZA (1) ZA986874B (id)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4803935B2 (ja) * 1999-10-08 2011-10-26 アフィニアム・ファーマシューティカルズ・インコーポレイテッド Fabi阻害剤
EP1121933A1 (en) * 2000-02-02 2001-08-08 Pfizer Products Inc. Premixed alatrofloxacin injectable compositions
EP1560584B1 (en) * 2001-04-06 2009-01-14 Affinium Pharmaceuticals, Inc. Fab i inhibitors
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
JP4880448B2 (ja) 2003-03-17 2012-02-22 アフィナム ファーマシューティカルズ,インコーポレーテッド 複数の抗生物質を含む組成物、及びそれを用いる方法
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
WO2007053131A2 (en) 2004-06-04 2007-05-10 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as antibiotic agents
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
CA2658506C (en) 2006-07-20 2016-01-26 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab 1 inhibitors
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
KR101720885B1 (ko) 2012-06-19 2017-03-28 데비오팜 인터네셔날 에스 에이 (e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
WO2015164859A1 (en) * 2014-04-25 2015-10-29 Naurex, Inc. Stable compositions of neuroactive peptides
LT3419628T (lt) 2016-02-26 2021-01-25 Debiopharm International Sa Medikamentas diabetinėms pėdų infekcijoms gydyti
WO2019148294A1 (en) 2018-02-02 2019-08-08 Interface Biologics, Inc. Dimeric dexamethasone prodrug compositions and uses thereof
WO2021220061A2 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
WO1995019361A1 (en) 1994-01-18 1995-07-20 Pfizer Inc. Process and intermediates for preparing naphthyridonecarboxylic acid salts
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
ES2117426T3 (es) 1995-06-06 1998-08-01 Pfizer Forma cristalina de la sal anhidra compuesta de los acidos 7-((1a,5a,6a)-6-amino-3-azabiciclo(3.1.0.)hex-3-il)-6-fluoro-1-(2,4-difluorofenil)-1,4-dihidro-4-oxo-1,8-naftiridina-3-carboxilico y metanosulfonico.
ES2178701T3 (es) * 1995-06-15 2003-01-01 Pfizer Procedimiento para preparar derivados del acido azabiciclo naftriridina carboxilico que comprenden un dipeptido.
WO1997007800A1 (en) 1995-08-29 1997-03-06 Pfizer Inc. Zwitterionic forms of trovafloxacin
TR199800340T1 (xx) 1995-08-29 1998-06-22 Pfizer Inc. �n-ila� 6-N-(L-ALA-L-ALA)-trovafloksasin polimorflar�.
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
JP2001512133A (ja) 2001-08-21
HN1998000106A (es) 1999-01-08
TW538043B (en) 2003-06-21
CA2296466A1 (en) 1999-02-11
IL134156A0 (en) 2001-04-30
AU734863B2 (en) 2001-06-21
OA11281A (en) 2002-11-19
CO4970688A1 (es) 2000-11-07
NO20000485D0 (no) 2000-01-31
EA002120B1 (ru) 2001-12-24
EP1000086B1 (en) 2004-02-18
PA8456701A1 (es) 2000-05-24
US6194429B1 (en) 2001-02-27
PT1000086E (pt) 2004-05-31
BR9811580A (pt) 2000-08-22
DE69821767T2 (de) 2005-01-13
KR20010022495A (ko) 2001-03-15
ZA986874B (en) 2000-01-31
HRP980417A2 (en) 1999-08-31
YU2500A (sh) 2002-09-19
SK1012000A3 (en) 2000-09-12
TNSN98146A1 (fr) 2005-03-15
IS5339A (is) 2000-01-14
PL338477A1 (en) 2000-11-06
BG104105A (bg) 2000-08-31
NZ502249A (en) 2001-11-30
PE103799A1 (es) 1999-10-25
EP1000086A1 (en) 2000-05-17
AR015417A1 (es) 2001-05-02
DZ2576A1 (fr) 2003-02-22
AP9801310A0 (en) 1998-09-30
JP3463928B2 (ja) 2003-11-05
HUP0004793A3 (en) 2001-10-29
GT199800112A (es) 2000-01-15
HRP980417B1 (en) 2002-10-31
DE69821767D1 (de) 2004-03-25
AP1031A (en) 2001-12-21
AU8236898A (en) 1999-02-22
WO1999006430A1 (en) 1999-02-11
ATE259827T1 (de) 2004-03-15
HUP0004793A2 (hu) 2001-04-28
UY25113A1 (es) 2000-12-29
CN1265671A (zh) 2000-09-06
DK1000086T3 (da) 2004-05-17
EA200000086A1 (ru) 2000-08-28
NO20000485L (no) 2000-03-27
CA2296466C (en) 2003-04-15
ES2214716T3 (es) 2004-09-16
MA24626A1 (fr) 1999-04-01

Similar Documents

Publication Publication Date Title
ID22931A (id) Komposisi-komposisi herbisidal
DK1298194T3 (da) Staniolholdige sammensætninger
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
PT945132E (pt) Composicao de ibuprofeno
DE69832516D1 (de) Isoflavon-enthaltende zusammensetzungen
ID16251A (id) Komposisi-komposisi pembasmi kuman
ID26549A (id) Komposisi-komposisi epotilon
ATE367793T1 (de) Schweisshemmende zusammensetzungen
FI974241A0 (fi) BPM-15 -koostumukset
DE69803761D1 (de) Schmierölzusammensetzungen
DE69826477D1 (de) Flammhemmende zusammensetzungen
DE69919953D1 (de) Funktionelle zusammensetzungen
ATE469550T1 (de) Antiparasitäre zusammensetzungen
ID24458A (id) Modifikasi rheologi in-sito poliolefin
ID25508A (id) Komposisi dematologis
DE69935172D1 (de) Imidosilan Zusammensetzungen
DE69829605D1 (de) Chondroitinase enthaltende Zusammensetzungen
ATE209959T1 (de) Mikroverkapselte zusammensetzungen
DE69733072D1 (de) Farbschonende zusammensetzungen
DE69719442D1 (de) Frisierschaum-Zusammensetzungen
PT1014987E (pt) Composicoes orais de levosimendano
ID27889A (id) Komposisi-komposisi kopolimer polisiklik
DE69617029D1 (de) Organoton-zusammensetzungen
NO984662L (no) Vann-i-olje-emulsjonsgj°dningsstoff-sammensetninger
ID24374A (id) Komposisi-komposisi parenteral alatrofloksasin